New Leadership at Comar

Image courtesy of Comar Brian Larkin
The medical molding and packaging specialist has named Brian Larkin President and CEO. He succeeds Mike Ruggieri, who led the company for 15 years.

Medical molding and packaging specialist Comar has named Brian Larkin President and CEO, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors.

Under Ruggieri’s 15 years of leadership, Comar evolved from a single-site, family-owned business to a multinational company with expanded customer relationships, broad innovation and design resources, and state-of-the-art manufacturing capabilities, said Comar in the announcement.

"Brian is the right leader for Comar,” said Ruggieri. “Brian’s extensive background in the healthcare industry combined with his innate business development skills should help Comar strengthen partnerships, develop strategic alliances, and expand our international sales presence. In addition, we believe his customer-centric leadership style will help focus Comar as we pursue our strategic ambitions.”

Comar has expanded at a rapid pace recently. In November of last year, it moved into a 160,000-square-foot facility near its former location in West Bend, IN, tripling its manufacturing footprint. In January 2020, it acquired iMARK Molding, a custom contract manufacturer based near Minneapolis serving the medical device industry. Comar currently operates 11 manufacturing and distribution facilities.

Headquartered in Voorhees, NJ, Comar offers injection molding, injection blow molding, injection stretch blow molding, and extrusion blow molding, in addition to a number of value-added service offerings.

Larkin comes into the Comar fold with a career that spans more than three decades of leadership roles in public and private-equity-backed companies focused on the medical device and pharmaceutical sectors. Larkin has held several key executive positions over the years, including President and CEO of SP Industries, Vice President and General Manager of Becton Dickinson's U.S. Diabetes Care business, Senior Vice President and General Manager for LifeCell Corp., and Corporate Vice President of Integra Lifesciences. He also currently serves on the Board of Directors for Dynatronics Corp.

"I am excited to build upon the strong foundation that Mike and his team have established at Comar and [am] eager to contribute to its next phase of growth," said Larkin in a prepared statement. "I look forward to partnering with Comar's employees and valued customers to capitalize on emerging growth trends in the medical and packaging industries while continuing to provide the highest quality products and services.”

Comar is majority owned by Morgan Stanley Capital Partners.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish